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Epstein–Barr virus LMP1 induces focal adhesions and
epithelial cell migration through effects on integrin-α5 and
N-cadherin
LR Wasil1 and KHY Shair1,2
Epstein–Barr virus (EBV) is a γ-herpesvirus associated with human epithelial and B-cell malignancies. The EBV latent membrane
protein (LMP) 1 is expressed in nasopharyngeal carcinoma (NPC) and promotes oncogenic intracellular signaling mechanisms.
LMP1 also promotes a pro-migratory phenotype through potential effects on cell surface proteins, as expression of LMP1 induces
an epithelial–mesenchymal transition (EMT) in epithelial cell lines. In this study, LMP1 was examined for potential effects on
cadherin and integrin surface interactions, and assessed for biological effects on adhesion and motility to fibronectin. Expression of
LMP1 in the non-tumorigenic epithelial cell line MCF10a induced an EMT-associated cadherin switch. The induced N-cadherin was
ligated and localized to the cell surface as determined by triton-solubility and immunofluorescence assays. In addition, LMP1
induced the assembly of focal adhesions (FAs) with increased production of fibronectin in MCF10a and NP460hTERT-immortalized
nasopharyngeal cells. Biochemical enrichment of fibronectin-associated proteins indicated that LMP1 selectively promoted the
recruitment of integrin-α5 and Src family kinase proteins to FA complexes. Neutralizing antibodies to N-cadherin and integrin-α5,
but not integrin-αV, blocked the adhesion and transwell motility of MCF10a cells to fibronectin induced by LMP1. LMP1-induced
transwell motility was also decreased by Src inhibition with the PP2 kinase inhibitor and short hairpin RNAs. These studies reveal
that LMP1 has multiple mechanisms to promote the adhesive and migratory properties of epithelial cells through induction of
fibronectin and modulation of cell surface interactions involving integrin-α5 and N-cadherin, which may contribute to the
metastatic potential of NPC.
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INTRODUCTION
Epstein–Barr virus (EBV) is a γ-herpesvirus associated with
epithelial and B-cell malignancies. The majority of adults are
asymptomatically infected, however, a subset develops cancer
with increased risk upon immunosuppression.1,2 EBV persists
latently in B cells with sporadic reactivation, but can also infect
oropharynx and gastric epithelia. The primary outcome of
epithelial infection is lytic replication, but in persistent latent
infection is associated with the oncogenic phenotypes of
nasopharyngeal carcinoma (NPC) and gastric carcinoma.3 EBV-
infected NPC represents approximately 78 000 new annual cancer
cases, with higher incidence in specific geographical regions such
as Southeast Asia.1,4 Clonal EBV infection is consistently detected
in NPC, and expresses a type II latency program that includes the
expression of the membrane proteins latent membrane protein 1
(LMP1), LMP2A, LMP2B, the EBNA1 episome maintenance protein,
and BART and EBER non-coding RNAs.5
The transforming and oncogenic potential of the putative viral
oncoprotein LMP1 have been characterized both in vitro and
in vivo. LMP1 transforms rodent fibroblasts, promotes growth in
soft agar, forms tumors in nude mice and enhances the migration
of epithelial cell lines.6–8 Transgenic mice expressing LMP1 from
the epithelial-specific keratin-14 promoter have increased
formation of hyperproliferative papillomas, and with LMP2A
demonstrate co-operative induction of invasive carcinomas by
chemical carcinogens.9 The immortalization of B cells by EBV is
also dependent on LMP1 expression.2 LMP1 is a constitutively
active transmembrane protein that interacts through the cyto-
plasmic domains (C-terminal activation regions—CTAR 1 and 2)
with tumor necrosis receptor family adapter molecules (TRAFs) to
activate oncogenic mechanisms including phosphoinositide
3-kinase (PI3K)/protein kinase B (Akt), epidermal growth factor
receptor (EGFR), extracellular signal-regulated kinase (ERK) and
nuclear factor kappa-light-chain-enhancer of activated B cells
(NFκB).6,7,10–12 LMP1 may also regulate extracellular interactions
through effects on junctional plakoglobin, E-cadherin and
N-cadherin.8,13–15 Plakoglobin and E-cadherin expression levels
are decreased in NPC, but increased expression of N-cadherin
correlates with advanced stage metastasis.8,16,17 Molecular
characteristics of epithelial–mesenchymal transition (EMT) may
contribute to metastasis, and one hallmark is the induction of a
cadherin switch.18 In epithelial and NPC cell lines, LMP1 expression
decreases junctional plakoglobin levels and induces a cadherin
switch with EMT-associated morphological changes.3,8,13–15,19–21
These molecular effects and increased actin polymerization
contribute to LMP1-mediated epithelial cell motility and
spreading, and suggest that LMP1 may modulate extracellular
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interactions involving integrin binding to the extracellular matrix
(ECM) and cadherin ligations to neighboring cells.8,22–24
There are few authenticated nasopharyngeal epithelial cell lines
that are not immortalized by other viral oncoproteins or
potentially contaminated with HeLa cells.25 In this study, the
effects of LMP1 were largely assessed in the spontaneously
immortalized non-tumorigenic, non-metastatic breast epithelial
cell line MCF10a. In these cells, LMP1 induced features of EMT and
increased adhesion and transwell migration to fibronectin.
Inhibition of integrin-α5 or N-cadherin ligation, and Src kinase
activity decreased LMP1-induced adhesion and motility. A novel
induction of focal adhesions (FAs) by LMP1 was also identified in
additional epithelial cell lines of nasopharyngeal (NP460hTERT)
and non-nasopharyngeal (U2OS) origins. Further characterization
by enrichment of FAs in MCF10a cells isolated with fibronectin-
coated magnetic beads demonstrated increased levels of integrin-
α5 and Src. These data indicate that LMP1 can modulate the
recruitment of cell surface proteins resulting in the constitutive
assembly of FAs and ligation of N-cadherin, providing mechanistic
insight into LMP1-mediated induction of adhesion and motility to
ECM in epithelial cells.
RESULTS
LMP1 induces EMT markers in MCF10a cells
LMP1 induces a cadherin switch and promotes the migration of
the NPC cell line C666-1.8,14 To investigate the activity of LMP1 in a
non-cancerous cell line, LMP1 was stably expressed by retroviral
transduction in MCF10a cells, a cell line susceptible to EMT
inducers such as transforming growth factor-β.26 In contrast to the
epithelial morphology of pBabe vector control cells, LMP1
expression induced an ECM-independent elongated mesenchymal
morphology on uncoated and fibronectin-coated surfaces
(Figure 1a). LMP1 decreased E-cadherin protein levels approxi-
mately 70% and increased N-cadherin 42-fold in MCF10a cells,
which was consistent in C666-1 cells (Figure 1b).14 However,
β-catenin levels, a component of the cadherin junctional complex,
were not consistently changed by LMP1 expression between cell
lines (Figure 1b). N- and E-cadherin were modulated transcrip-
tionally by LMP1 expression (Figure 1c). The change in cadherin
expression and transition to a mesenchymal morphology indicate
that LMP1 induces molecular and morphological features
associated with EMT in MCF10a cells.
To evaluate potential changes in adherens junction-associated
cadherins, confluent monolayers of MCF10a cells were analyzed
for N-cadherin, E-cadherin and β-catenin (Figure 2a). In pBabe
cells, N-cadherin was not detected, but E-cadherin and β-catenin
colocalized at the cell periphery. In contrast, LMP1-expressing cells
had weak E-cadherin staining with colocalized N-cadherin and
β-catenin staining at the cell periphery, indicative of adherens
junctions. N-cadherin C-terminal fragments may also regulate
cAMP response element-binding protein (CREB)-mediated tran-
scription, but cytoplasmic staining of N-cadherin was not detected










































































































































Figure 1. LMP1 induces EMT in MCF10a cells. (a) Comparison of MCF10a stable cell line morphologies seeded on fibronectin-coated and
-uncoated surfaces by phase contrast. (b, c) Quantitation of E-cadherin and N-cadherin levels by immunoblot and quantitative RT–PCR
analyses. Immunoblot comparisons were performed in MCF10a and C666-1 stable cell lines. Normalized fold-change is calculated relative to
the pBabe control set to 1. 'n' indicates the number of independent biological replicates and error bars indicate s.d. For quantitative RT–PCR,
experiments were performed with technical triplicates and averaged from two biological replicas.
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occurs at potential sites of intercellular interaction on the cell
surface.27 To assess the levels of ligated N-cadherin, MCF10a cells
were analyzed by a triton X-100-solubility assay. LMP1 increased
soluble and insoluble N-cadherin, but the proportions of
N-cadherin in each fraction did not change (Figure 2b). In
comparison, the triton-soluble protein glyceraldehyde
3-phosphate dehydrogenase (GAPDH) was excluded from the
triton-insoluble fraction supporting fraction purity (Figure 2b). To
further investigate if ligated N-cadherin is increased by LMP1,
MCF10a cells were analyzed by a calcium switch assay, in which
N-cadherin ligation at the cell surface is disrupted by the chelating
agent EDTA. The re-addition of calcium restores functional
cadherins, which can be detected as a complex in the triton-
insoluble fraction. Before treatment with EDTA (T0), insoluble
N-cadherin was in both vector control and LMP1-expressing cells
(Figure 2c). Treatment with EDTA for 30 min specifically decreased
insoluble N-cadherin to trace levels, indicating effective disruption
of ligated N-cadherin in both cell lines (Figure 2c). After EDTA
removal and washes, less adherent cells may be recovered at early
time points, which is reflected by the decrease in GAPDH levels at
5- to 15-min calcium switch. However, comparison of N-cadherin
fractions from the same harvest indicates that ligation is rapidly
re-initiated as early as 5 min in the triton-insoluble fraction
(Figure 2c). These data support that the insoluble fraction
contains ligated N-cadherin occurring at increased levels in
LMP1-expressing cells; however, the amount of ligated N-cadherin
was proportional to its relative abundance in each cell line. These
data indicate that LMP1 induces EMT and increases N-cadherin
expression and ligation at the cell surface.
LMP1-induced migration to fibronectin requires N-cadherin and
integrin-α5
LMP1 can enhance transwell migration of NPC cells to fibronectin,
which may be mediated by enhanced intercellular and ECM
interactions.8 In addition, loss of E-cadherin and plakoglobin
contributes to LMP1-induced motility in multiple epithelial cell
lines.3,8,14,15,21 To determine if LMP1 enhances MCF10a migration
with the potential contribution of N-cadherin and integrins,
transwell migration to fibronectin was assessed in the presence
of neutralizing antibodies to N-cadherin, integrin-α5 or -αV.
N-cadherin neutralization was evaluated in cadherin preserving
and cleaving conditions. In cadherin preserving conditions, cells
were dissociated by trypsin in the presence of calcium to protect
cadherins from protease digestion, and filtered through a cell
strainer to generate single cell suspensions.28 Expression of LMP1
significantly increased migration of MCF10a cells to fibronectin
and treatment with N-cadherin neutralizing antibody decreased
LMP1-induced migration (Figures 3a, P= 0.01). In contrast,
LMP1-induced migration did not decrease in cadherin cleaving
conditions (0.05% trypsin-EDTA) with N-cadherin neutralizing
antibodies (Figure 3a). These findings indicate that the blocking
effect requires intact N-cadherin at the time of neutralization,
and suggests that restoration of LMP1-induced migration
post-cadherin cleavage may result from re-expression of surface
cadherins, which could be restored within hours of
trypsinization.29
Integrin-α5 and -αV are the principal α-integrins that bind
fibronectin. To examine effects independent of cadherin interac-
tions, transwell migration was assessed in cadherin cleaving
conditions with neutralizing antibodies to integrin-α5 and -αV.
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Figure 2. LMP1 induces a cadherin switch at the cell surface. (a) Immunofluorescence staining for E-cadherin, N-cadherin and β-catenin in
MCF10a stable cell lines. Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI) and imaged by confocal microscopy. Inset, images
were digitally zoomed to display staining at the cell periphery (arrows). (b) Triton-solubility and immunoblot analysis of soluble (S) and
insoluble (I) N-cadherin from MCF10a stable cell lines. The percentage of N-cadherin in each fraction was quantified by densitometry from
three independent experiments (n). (c) Ligation of cell surface N-cadherin in MCF10a cells was assessed by EDTA treatment followed by a
calcium switch, and analyzed by immunoblotting for soluble (S) and insoluble (I) N-cadherin in a triton-solubility assay.
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Neutralizing integrin-α5 decreased migration of pBabe cells and
reduced migration of LMP1-expressing cells to pBabe levels,
supporting that integrin-α5 is a primary integrin for binding
to fibronectin (Figures 3b, P= 0.01). In contrast, integrin-αV
neutralizing antibody, which inhibits LMP2A-induced migration
to fibronectin, did not affect migration of pBabe or LMP1-
expressing cells (Figure 3b).30 These results indicate that
integrin-α5, but not integrin-αV, is required for LMP1-induced
migration to fibronectin in MCF10a cells.
To evaluate effects of LMP1 on ECM-mediated adhesion, cell
attachment was continuously monitored for 2 h using the
xCelligence RTCA instrument, which measures electrical impedance
as a determinant of cell attachment. Attachment of MCF10a cells
was compared on fibronectin-coated and -uncoated surfaces.
Fibronectin increased attachment of both pBabe and LMP1-
expressing cells (Figures 4a, P=0.05), confirming that MCF10a cells
respond to fibronectin. LMP1 also increased attachment of MCF10a
cells to uncoated surfaces (Figures 4a, P=0.01). Although the fold-
changes in attachment varied between experiments, the increase
was consistent across independent experiments (Figures 4a, 3/3
experiments). Neutralizing antibodies to integrin-α5 decreased
attachment of pBabe cells (2/3, P=0.05), and consistently inhibited
attachment of LMP1-expressing cells (3/3, P=0.05) to levels
comparable to pBabe cells (Figure 4b). In agreement with the
findings in transwell migration (Figure 3b), neutralizing integrin-αV
did not affect attachment of pBabe or LMP1-expressing cells
(Figure 4c).30 These data indicate that LMP1 enhances attachment
of MCF10a cells to fibronectin through effects on integrin-α5.
Induction of FAs by LMP1 is dependent on Src and contributes to
enhanced migration
Integrin binding to ECM initiates assembly of FAs leading to actin
polymerization, migration, and the formation of filopodia and
lamellipodia.31 To investigate potential LMP1-mediated effects,
FAs were imaged by vinculin staining and by detection of
polymerized actin with phalloidin (Figure 5a and b). In MCF10a
cells on uncoated surfaces, vinculin was predominantly cytoplas-
mic with few FAs in pBabe cells and specific foci colocalized at
intercellular regions indicative of adherens junctions (Figure 5a,
arrow). In contrast, abundant FAs, identified by punctate vinculin
staining and emanating strands of polymerized actin, were
detected in LMP1-expressing cells indicating that LMP1 efficiently
induced the assembly of FAs without exogenous addition of
fibronectin coating (Figure 5a, arrowhead). FAs detected in LMP1-
expressing cells were more abundant along the cell periphery,
illustrated by lamellipodia structures lining the leading edge. On
fibronectin-coated surfaces, both pBabe and LMP1-expressing
MCF10a cells induced abundant FAs with prominent filopodia and
lamellipodia (Figure 5a). The induction of FAs in the absence of
fibronectin coating was further evaluated in additional epithelial
cell lines, NP460hTERT and U2OS (Figure 5b). In hTERT-
immortalized NP460 nasopharyngeal cells, stable expression of
LMP1-induced FAs similar to the effect in MCF10a cells (Figure 5b).
Basal levels of FAs are higher in U2OS cells and predominantly
localize to the cell periphery; however, LMP1 further increased the
number of FAs localized throughout the cell (Figure 5b). These
data support that LMP1 promotes assembly of FAs in multiple
epithelial cell types. In addition, the relative levels of LMP1
expression varied between stable cell lines but were comparable
to the range detected in EBV-infected epithelial and B cells, and an
NPC tumor (Supplementary Figure 1). By targeting a conserved
epitope and nucleotide sequence in LMP1 strain variants, the
relative LMP1 levels were higher in the NPC xenograft (C15 tumor)
compared with trace levels in cultured epithelial cell lines (293,
NP460hTERT, HK1) infected de novo (Supplementary Figure 1A),
indicating that even trace levels of LMP1 in stable
NP460hTERT cells, comparable to the low levels in EBV-infected






















































































































Figure 3. LMP1-induced migration of MCF10a cells to fibronectin is dependent on integrin-α5 and N-cadherin. MCF10a stable cell lines were
assayed by transwell migration to fibronectin. Neutralizing antibodies to (a) N-cadherin, and (b) integrin-α5 and -αV, were assessed for effects on
transwell motility. N-cadherin blocking was compared in cadherin preserving and cleaving conditions. Fold-change in migration was calculated
from three independent experiments (n) with error bars indicating s.d., and compared by the Student’s t-test. *P=0.01; NS, not significant.
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To further investigate if LMP1 promotes the assembly of FAs by
modulating total integrin levels, MCF10a cells were analyzed by
fractionation and flow cytometry for surface integrins. Detection
of transmembrane LMP1, but not soluble GAPDH, indicated
enrichment of membrane proteins. Integrin-α5 and -αV levels
were equivalent in pBabe and LMP1-expressing cells, supporting
that LMP1 does not promote FA assembly by regulating total
integrin levels (Figure 5c). In contrast, flow cytometry detected
increased cell surface levels of integrin-α5, but not integrin-αV, by
LMP1 expression (Figure 5c). However, surface levels of integrin-α5
were not affected by fibronectin coating suggesting that
additional factors may contribute to induction of FAs.
FAK and Src are recruited to FA signaling complexes to mediate
downstream intracellular signaling. Src inhibition prevents the
activation of Rac, Rho and Cdc42, impeding actin polymerization
and migration.31 To investigate the role of FA signaling in LMP1-
induced migration, Src was inhibited with the Src family kinase
inhibitor PP2 or by short hairpin RNA knockdown in MCF10a cells,
and assessed by transwell migration to fibronectin. Treatment of
MCF10a cells with PP2 at 400 and 800 nM decreased LMP1-
induced migration (Figures 5d, P= 0.01), but did not affect control
cell migration. Transient knockdown of Src further decreased
migration in LMP1-expressing cells, which also occurred in pBabe
cells and may be indicative of a kinase-independent effect not
specific to LMP1 expression (Figures 5e, P= 0.01). To assess the
effects of Src inhibition on FA assembly, MCF10a cells were treated
with two doses of PP2 (200 and 800 nM). At the sub-optimal
inhibitory dose (200 nM), residual levels of actin polymerization
were still evident but were inhibited by the higher PP2 dose
(800 nM; Figure 5f). The induction of actin polymerization by LMP1
in the absence of fibronectin-coating was also inhibited by PP2 at




















































































































































































































































Effect of blocking antibody to integrin-α5
on adhesion to fibronectin
Effect of blocking antibody to integrin-αV 
on adhesion to fibronectin
Figure 4. LMP1-induced adhesion of MCF10a cells to fibronectin is dependent on integrin-α5. Attachment of MCF10a stable cell lines was
assayed by RTCA for 2 h post-seeding. (a) Comparison of MCF10a stable cell lines adhering to fibronectin (FN)-coated and -uncoated surfaces.
(b, c) The effect of neutralizing antibodies to (b) integrin-α5 and (c) integrin-αV on the adhesion of MCF10a stable cell lines to fibronectin-
coated surfaces. Normalized cell index values were calculated from electrical impedance readings as a result of cell attachment, and
normalized to the starting value at the time of seeding. A representative cell attachment curve is shown, averaged from a min. of triplicate
wells with s.d. displayed. At 2 h post-seeding, fold-change in attachment from three independent experiments (n) was calculated and analyzed
by the Student’s t-test. *P= 0.01; **P= 0.05; NS, not significant. In one comparison, the t-test was not significant in all three experiments and
the number of experiments in which the t-test was significant is indicated in parenthesis (2/3, two out of three experiments).
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formation of FAs, and downstream activation of Src is required for
LMP1-induced migration.
LMP1 promotes the recruitment of integrin-α5 and Src to FAs
To determine the potential mechanism for LMP1-induced FAs, FA
complexes were isolated using fibronectin-coated magnetic beads
and analyzed for associated proteins. The fibronectin-bound
complexes were lysed in non-ionic detergent, and both non-FA
(NFA) and FA-enriched fractions were collected and assessed for
FA-enriched proteins (actin, Src, integrin-α5 and -αV) or NFA
proteins, including plasma membrane-associated [epidermal
growth factor receptor (EGFR) and protein kinase B (Akt)] and
cytosolic (GAPDH) proteins. In the FA fraction, detection
of low levels of epidermal growth factor receptor (EGFR) and
protein kinase B (Akt) without GAPDH indicated
co-purification with trace levels of integral and plasma



















































































































































































































DMSO PP2 200nM PP2 800nM
Vinculin (A488)
Phalloidin-TRITC
Figure 5. Src contributes to LMP1-induced FAs and migration to fibronectin. (a, b) Immunofluorescence staining of MCF10a, NP460hTERT and
U2OS stable cell lines for FA markers (vinculin and phalloidin) and imaged by confocal microscopy. Enlarged images display individual FAs
(arrowhead) and adherens junctions (arrow). (c) Immunoblot analysis for integrin-α5 and -αV from cytosolic and membrane fractions of MCF10a
cell lines and flow cytometry analyses of non-permeabilized MCF10a cells for surface integrin-α5 and -αV. MFI, mean fluorescence intensity.
(d, e) Inhibition of Src in MCF10a cells with (d) increasing doses of the PP2 Src kinase inhibitor and, (e) Src short hairpin RNA knockdown by
transient transduction was analyzed by transwell migration to fibronectin. The average knockdown (% KD) from three independent
experiments (n) is indicated, with one representative Src immunoblot shown. Fold-change in migration was calculated from independent
experiments with error bars indicating s.d., and compared by the Student’s t-test. *P= 0.01. (f) Immunofluorescence staining for the assembly of
FAs (vinculin and phalloidin) in MCF10a cells treated with PP2 at 200 nM and 800 nM, on fibronectin-coated and -uncoated surfaces.
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between integrin, epidermal growth factor receptor (EGFR) and
protein kinase B (Akt) pathways (Figure 6a).32,33 In contrast, high
levels of actin were detected in the FA fraction. Phosphorylated
Src (Y416) and Lyn (Y507) in the FA fraction were selectively
increased in LMP1-expressing cells, and although these tyrosine-
specific antibodies may cross-react with other Src family kinase
members, total levels of Src and Lyn were also correspondingly
increased (Figure 6a). Quantitation of recruitment to the FA
fraction (FA:NFA ratio) indicated selective enrichment of Src and
integrin-α5 in LMP1-expressing cells (6.6-fold and 4.4-fold,
respectively) without affecting integrin-αV levels (Figure 6a).
LMP1 was detected in both NFA and FA fractions, suggesting
that LMP1 may associate with FA complexes (Figure 6a). To further
analyze if the LMP1-mediated selective enrichment of Src to FAs is
dependent on integrin-α5, MCF10a cells were pretreated with
integrin-α5 neutralizing antibodies and re-analyzed for FA
complexes. Pretreatment with integrin-α5 neutralizing antibodies
inhibited Src recruitment to the FA fraction, which was modestly
increased in LMP1-expressing cells treated with isotype control
antibody (1.7-fold; Figure 6b). In addition, LMP1 may also induce
FAs by increasing production of fibronectin. LMP1 expression in
MCF10a and NP460hTERT cells increased fibronectin transcripts
and protein levels (Figure 6c and d); however, this was only
detectable in cell lines with low (MCF10a) or intermediate
(NP460hTERT) levels of basal fibronectin, and not in cells with
high basal levels (U2OS). Collectively, these findings indicate that
LMP1-mediated induction of fibronectin, integrin-α5-dependent
FAs and N-cadherin ligations represents multiple mechanisms by
which LMP1 targets extracellular interactions to promote adhesive
and migratory properties in epithelial cells.
DISCUSSION
Expression of LMP1 in rodent fibroblast and epithelial carcinoma
cell lines promotes cell growth and motility.4,6 LMP1 regulates cell
motility by the modulation of junctional proteins including
plakoglobin and E-cadherin, secretion of the matrix metallo-
proteinase 9 and potentially through the induction of
N-cadherin.7,8,10,11,14,19,34,35 In this study, LMP1-mediated effects
on cell surface interactions were further evaluated for integrin and
cadherin-mediated interactions in the pre-malignant cell line
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Figure 6. LMP1 promotes surface recruitment of integrin-α5 and production of fibronectin. (a) Immunoblot analysis of NFA and FA-enriched
fractions for recruitment of FA-associated proteins in MCF10a stable cell lines. The fold-change of Src and integrin-α5 levels from two
independent experiments, relative to pBabe cells (set to 1) is represented as a ratio of FA:NFA levels. (b) The effect of neutralizing antibodies to
integrin-α5 on the recruitment of Src to FAs was analyzed by immunoblotting. (c, d) Quantitative RT–PCR and immunoblot analysis of
fibronectin in MCF10a, NP460hTERT and U2OS cells. (c) Fibronectin transcript was normalized to GAPDH with fold-change quantified from
biological replicas (n), relative to MCF10a LMP1 cells set to 1. (d) Fibronectin expression was detected by immunoblot and quantified on LICOR
Odyssey Infrared Imager. Fold-change in MCF10a cells was determined from triplicate biological replicas.
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spontaneous assembly of FAs, potentially through increased
production of ECM proteins, and increases the adhesion and
transwell motility to fibronectin by promoting integrin-α5-
mediated FAs.36 The inhibition of migration by N-cadherin
neutralizing antibody indicates that intercellular N-cadherin
ligation may promote collective cell migration or inhibit down-
stream pro-migratory signaling mechanisms. For instance, block-
ing N-cadherin ligation can prevent its association with the
receptor tyrosine kinase fibroblast growth factor receptor (FGFR),
resulting in the inhibition of extracellular signal-regulated kinase
(ERK)-dependent activation of matrix metalloproteinase 9 tran-
scription, thus inhibiting invasion of breast cancer epithelial
cells.3,37 The potential of N-cadherin as a therapeutic target has
also been explored in xenograft models of melanoma, prostate
and pancreatic cancers by inhibiting N-cadherin ligation with
peptide antagonists and blocking antibodies.38–40
The process of epithelial cell adhesion to the substratum, and
suspended migration to ECM proteins, is a dynamic process that
involves opposing interactions with the stroma. ECM proteins such
as fibronectin exist as a substratum-bound form and soluble
ligand in plasma that are mimicked by adhesion and transwell
migration assays, respectively. Migration of cells to these forms is
defined as haptotactic and chemotactic migration, respectively,
and may be regulated by differential signaling mechanisms.41
Metastatic cells must acquire the ability to detach from the
primary site, sequentially intra- and extra-vasate from endothelial
cells, and finally re-attach at secondary sites.18 These reciprocal
changes are also observed at the molecular level by reversal of
EMT to MET (mesenchymal–epithelial transition) as cells migrate
to distal sites.18 Therefore, the ability of LMP1 to increase adhesion
and chemotaxis to fibronectin may mimic these cycling processes
during metastasis.
In response to fibronectin, LMP1 specifically recruited integrin-
α5, but not integrin-αV, in mediating adhesion and motility
(Figures 3 and 4). The induction of integrin-mediated effects by
LMP1 was not mediated by changes in total integrin-α5 levels, and
although surface integrin-α5 levels were unaffected by fibronectin
coating, LMP1 may promote conformationally active integrins
once recruited to the cell surface (Figure 5c). In addition, the
increased deposition of fibronectin by LMP1 may directly
contribute to the activation of FAs (Figure 6c and d). Previous
studies in NPC cell lines and biopsies have identified additional
LMP1-induced integrins including integrin-α6 and -αV.42,43 Inter-
estingly, integrin-α6 expression correlates with LMP2A levels and
contributed to LMP2A-mediated migration and invasion of
primary epithelial cells.44 In addition, LMP2A greatly increases
membrane-localized integrin-αV and blocking integrin-αV ligation
prevents LMP2A-induced migration to fibronectin, collagen and
serum.30 The respective preference of LMP1 and LMP2A for
integrin-α5 and -αV could reflect the selection of integrin-α5 for
fibronectin and the broader ligand repertoire of integrin-αV, and
may allow LMP1 and LMP2A to respond to changing extracellular
environments.
Integrins are also required for EBV infection of epithelial cells
and localize to the virological synapse, which mediates transfer of
cell-associated virions to epithelial cells that do not express the
primary EBV receptor, CD21.45 Transfer of cell-associated virus and
direct cell-free binding can be blocked by competition with
peptides or natural integrin ligands, such as fibronectin and
vitronectin, or by specific knockdown of integrin-αV to inhibit
fusion of the EBV gHgL 2-part complex with epithelial cells.45,46
Therefore, integrins participate in multiple mechanisms of EBV
pathogenesis in epithelial cells including LMP1- and LMP2A-
induced cell migration and EBV infection.
Interaction of tumor cells with the microenvironment is thought
to also contribute to initiation of metastasis. It is postulated that
the switch to metastatic outgrowth is mediated by ECM proteins,
integrin activation and actin stress fiber remodeling.47,48
Fibronectin is associated with poor prognosis in multiple types
of epithelial cell malignancies and is also induced in NPC in
association with EMT markers.49,50 In this study, the enhanced
response of LMP1-expressing cells to fibronectin and the
induction of EMT could potentially indicate a physiologically
relevant role for fibronectin in the metastatic phenotype of NPC. In
summary, this study indicates that LMP1 can modulate cell surface
interactions in addition to previously defined intracellular signal-
ing pathways, to regulate adhesive and motile phenotypes. The
induction of FAs and the ligation of N-cadherin suggest that LMP1
modulates the individual and collective migration of epithelial
cells. These mechanisms mediated by LMP1, and also possibly by
LMP2A, likely contribute to NPC metastasis, and it is possible that
the targeting of N-cadherin and integrin signaling may have
therapeutic potential for the treatment of metastatic NPC.
MATERIALS AND METHODS
Cell lines
MCF10a, NP460hTERT, C666-1 cells were maintained as previously
described and U2OS cells were maintained in Dulbecco’s modified Eagle’s
medium with 10% fetal bovine serum.14,25,51,52 C666-1 cells are derived
from an EBV-positive NPC tumor, but express negligible amounts of
endogenous LMP1.8,14,53 Stable cell lines were generated using pBabe
retrovirus expressing the LMP1 B958 strain.7 For fibronectin coating,
50 μg/ml fibronectin (Sigma, St Louis, MO, USA) was applied to tissue
culture plates overnight at 4 oC and rinsed on day of use.
Quantitative RT–PCR
Total RNA was purified with the RNeasy Mini Kit and 50 ng of RNA was
analyzed by the Quantifast Sybr-green RT-PCR kit (Qiagen, Venlo,
Netherlands). Primers were as follows, N-cadherin (5′-AAATTGAGCCTGA
AGCCAAC-3′ and 5′-GTGGCCACTGTGCTTACTGA-3′); E-cadherin (5′-CCTGG
GACTCCACCTACAGA-3′ and 5′-CTGCTTGGATTCCAGAAACG-3′); and
GAPDH (5′-TGCACCACCAACTGCTTAGC-3′ and 5′-GAGGGGCCATCCACAG
TCTT-3′). For fibronectin and LMP1 quantitation: fibronectin (5′-ACTGAGA
CTCCGAGTCAGCC-3′ and 5′-TTCCAACGGCCTACAGAATT-3′); LMP1 (5′-ACC
TTCTCTGTCCACTTGGA-3′ and 5′-AGAGTCCACCAGTTTTGTTG-3′) and
human-specific GAPDH to avoid detection of mouse GAPDH in NPC
xenografts, HsGAPDH (5′-AATCAAGTGGGGCGATGCTG-3′ and 5′-GTTCACA
CCCATGACGAACATG-3′). Reactions were performed on ABI 7900HT and
StepOne Plus instruments (Applied Biosystems, Waltham, MA, USA), values
were normalized to GAPDH and relative fold-change was calculated by the
ΔΔCt comparative method.
Immunoblot and immunofluorescence
Whole cell, cytosolic and membrane lysates were prepared as previously
described.7,30 Cell lysates were resolved on sodium dodecyl sulfate–
polyacrylamide gel electrophoresis, immunoblotted and quantified by
Image J densitometry (NIH, Bethesda, MD, USA) or on the LICOR Odyssey
Imager (Lincoln, NE, USA). For immunofluorescence, cells were fixed in 4%
paraformaldehyde, permeabilized with 0.1% Triton X-100 and stained for
FAs with vinculin antibody (1:400, Sigma) and TRITC-Phalloidin (0.2 μg/ml,
Sigma) according to the Focal Adhesion Staining Kit (Millipore, Billerica,
MA, USA). Immunofluorescence of N-cadherin, E-cadherin and β-catenin
was performed with the following modifications: 5% bovine serum
albumin block and incubation with 2.5 μg/ml primary antibody in block
overnight at 4 oC. Fluorescent secondary antibodies were used
at 5–10 μg/ml and counterstained with 4,6-diamidino-2-phenylindole or
Draq5. Antibodies were from: BD Biosciences (San Jose, CA, USA)
(E-cadherin, N-cadherin, β-catenin, integrin-α5, integrin-αV); Santa Cruz
Biotechnology (Dallas, TX, USA) (GAPDH, HSC70, β-catenin, Lyn, Fyn,
α− tubulin); Sigma (actin, vinculin); Cell Signaling Technologies (Danvers,
MA, USA) (Akt, pAkt, Src, pSrc, pLyn); Amersham (Marlborough, MA, USA)
(horseradish peroxidase-conjugated anti-mouse or anti-rabbit) and
Invitrogen (Grand Island, NY, USA) (Alexa Fluor 488 anti-mouse IgG and
Alexa Fluor 647 anti-rabbit IgG). EGFR antibody was a gift from Dr Shelton
Earp (UNC-Chapel Hill, NC, USA). LMP1 antibodies were from Santa Cruz
Biotechnology (clones CS1-4); Ascenion (Munich, Germany) (clones 8G3,
7G8, 7E10) or was produced from the S12 hybridoma.54 Cells were imaged
with confocal microscopes [Zeiss 710 (Jena, Germany) and Olympus FV500
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(Center Valley, PA, USA), University of North Carolina Microscopy Services
Laboratory; and Leica TCS SP2 upright (Wetzlar, Germany), University of
Pittsburgh Center for Biologic Imaging], acquired on a 63X oil objective,
with brightness and contrast equally adjusted across images.
Adhesion and transwell migration assays
Adhesion was measured with the xCelligence RTCA DP instrument (ACEA
Biosciences, San Diego, CA, USA). Trypsin-EDTA dissociated cells (20 000)
were seeded in 16-well electronic plates (E-plate 16), with or without
fibronectin coating (50 μg/ml). Blocking antibodies at 20 μg/ml (anti-
integrin α5 clone P1D6, Millipore; anti-integrin αV clone NKI-M9, Biolegend
(San Diego, CA, USA); or mouse IgG, Sigma) was incubated with dissociated
cells for 30min at 4 oC to minimize antibody internalization before
seeding. Electrical impedance was measured for a minimum of triplicate
wells and blanked to wells with media alone. Transwell migration was
performed as previously described with the following modifications:8
dissociation in 0.05% trypsin-EDTA for cadherin cleaving conditions, or
0.1% trypsin in 2mM CaCl2 and passed through a cell strainer to obtain
single cells for cadherin preserving conditions.28 The underside of
transwell was pre-coated with 10 μg/ml fibronectin and 100 000 cells
were seeded in reduced assay media (1% horse serum, no EGF). Blocking
treatments were performed by pre-incubation with neutralizing integrin
antibodies (20 μg/ml for integrin-α5 and 50 μg/ml for integrin-αV), or
equivalent amounts of mouse IgG control for 30min at 4 oC before seeding
in transwells. Knockdown of Src was performed by transient transduction
with Src short hairpin RNA retrovirus expressed from pRetroSuper
(Addgene #26982, Cambridge, MA, USA). Each biological replica experi-
ment (n) was assayed in duplicate wells and imaged for quadruplicate
fields per well. Migrated cells were counted using Image J software.
Flow cytometry
Live cells were stained for surface integrins with 1 μg primary antibody
(anti-integrin-α5 clone P1D6, anti-integrin-αV clone NKI-M9 or isotype
control) and 1 μg secondary antibody (Alexa Fluor 488 anti-mouse IgG).
Incubations were performed in 1% fetal bovine serum stain buffer for
20min at 4 oC, and analyzed on the BD Accuri C6 cytometer (BD
Biosciences) (UPCI Cytometry Facility).
FA enrichment
Fibronectin-coated magnetic beads (1 X 109 Epoxy M-270 beads,
Invitrogen) were blocked in 5% bovine serum albumin for 1 h at 37 oC,
and resuspended to ~ 1 million beads/ml in phosphate-buffered saline.
Sonicated beads (40 μl) were added to adherent cells pre-starved for 2 h in
0.5% delipidated bovine serum albumin (to minimize Rho activation). For
antibody blocking, cells were pre-incubated with 10 μg/ml anti-integrin α5
antibody for 30min at 4 oC. At 2 h, unbound beads were removed in cold
TBS-M (Tris-buffered saline with 1mM MgCl2 to preserve intact FAs) and
cells with mature FAs bound to beads were lysed (20mM Tris pH 7.6,
150mM NaCl, 0.1% NP-40, 2 mM MgCl2; supplemented with protease
and phosphatase inhibitor cocktails, Sigma). The FA fraction was isolated
by magnetic enrichment and eluted by boiling in 2X sodium dodecyl
sulfate–polyacrylamide gel electrophoresis sample buffer. The unbound
fraction was collected as the NFA fraction. Eluted proteins were analyzed
by immunoblotting using equal volumes of the same fraction equivalent to
1:200 NFA:FA cell equivalents.
Calcium switch assay
Cells were washed in calcium and magnesium-free phosphate-buffered
saline and treated with 4mM EDTA for 30min at 37 oC to dissociate ligated
cadherins. To initiate a calcium switch, MCF10a complete growth medium
was replenished and lysates from triton-solubility assays were prepared at
indicated time points as previously described.14 Equal number of cell
equivalents (1:1) from triton-soluble and triton-insoluble fractions were
analyzed by immunoblotting.
Statistics
All statistics was performed by two-tailed Student’s t-test, with biological
and technical replicates displayed in each figure legend. P-values were
calculated using the most stringent paired t-test method. For comparisons
of dissimilar variances calculated by F-test, s.d. are displayed for each
individual experiment over multiple time points (Figure 4).
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